Relative impact of incorporating pharmacokinetics on predicting in vivo hazard and mode of action from high-throughput in vitro toxicity assays.
The use of high-throughput in vitro assays has been proposed to play a significant role in the future of toxicity testing. In this study, rat hepatic metabolic clearance and plasma protein binding were measured for 59 ToxCast phase I chemicals. Computational in vitro-to-in vivo extrapolation was used to estimate the daily dose in a rat, called the oral equivalent dose, which would result in steady-state in vivo blood concentrations equivalent to the AC 50 or lowest effective concentration (LEC) across more than 600 ToxCast phase I in vitro assays. Statistical classification analysis was performed using either oral equivalent doses or unadjusted AC 50 /LEC values for the in vitro assays to predict the in vivo effects of the 59 chemicals. Adjusting the in vitro assays for pharmacokinetics did not improve the ability to predict in vivo effects as either a discrete (yes or no) response or a low effect level (LEL) on a continuous dose scale. Interestingly, a comparison of the in vitro assay with the lowest oral equivalent dose with the in vivo endpoint with the lowest LEL suggested that the lowest oral equivalent dose may provide a conservative estimate of the point of departure for a chemical in a dose-response assessment. Furthermore, comparing the oral equivalent doses for the in vitro assays with the in vivo dose range that resulted in adverse effects identified more coincident in vitro assays across chemicals than expected by chance, suggesting that the approach may also be used to identify potential molecular initiating events leading to adversity.
The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina 27709-2137, USA.
Barbara A
BA
Wetmore
John F
JF
Wambaugh
Stephen S
SS
Ferguson
Lili
L
Li
Harvey J
HJ
Clewell
Richard S
RS
Judson
Kimberly
K
Freeman
Wenjun
W
Bao
Mark A
MA
Sochaski
Tzu-Ming
TM
Chu
Michael B
MB
Black
Eric
E
Healy
Brittany
B
Allen
Melvin E
ME
Andersen
Russell D
RD
Wolfinger
Russell S
RS
Thomas
D000818:Animals; D057166:High-Throughput Screening Assays; D006801:Humans; D066298:In Vitro Techniques; D008962:Models, Theoretical; D010599:Pharmacokinetics; D051381:Rats; D018675:Toxicity Tests